Drug Trial Radar · NCT04776629
A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors
Last checked: Nov 19, 2026Latest source record: May 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
77
Actual
Start
Jun 30, 2021
Primary completion
Nov 11, 2022
Study completion Nov 11, 2022
Sponsor
- Lead sponsor
- AbcentraIndustry
- Sponsor type
- Industry
- First posted
- Mar 2, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 30 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of this proof-of-activity, phase 2 trial is to evaluate the safety and activity of orticumab in subjects with moderate to severe psoriasis and cardiometabolic risk factors.
Conditions
- Psoriasis
- Inflammation
- Coronary Artery Disease
- Cardiometabolic Syndrome
Interventions
OrticumabDrug
A human recombinant monoclonal antibody against a specific oxidized low-density lipoprotein (oxLDL) epitope
PlaceboDrug
Placebo for orticumab, containing all components of formulation except the active ingredient
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Percent Change From Baseline in Psoriasis Area Severity Index (PASI)Time frame: 106 days (Week 15)
- Percentage of Participants Achieving Treatment Success by the 5-point Static Investigator's Global Assessment Modified 2011 Version (sIGA) ScoreTime frame: 106 days (Week 15)
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
CCT- Research at the center for Dermatology and Plastic Surgery
Scottsdale, Arizona
Derm Institute & Skin Care Ctr., Inc.
Santa Monica, California
Orange County Research Center
Tustin, California
Blue Coast Research Center
Vista, California
Jacksonville Center for Clinical Research
Jacksonville, Florida
Dawes Fretzin Clinical Research Group, LLC
Indianapolis, Indiana
Las Vegas Clinical Trials
Las Vegas, Nevada
Excel Clinical Research
Las Vegas, Nevada
Vital Prospects Clinical Research Institute, PC
Tulsa, Oklahoma
SMS Clinical Research
Mesquite, Texas
Texas Dermatology and Laser Specialists
San Antonio, Texas
Center for Clinical Studies, LTD.LLP
Webster, Texas
CCT Research - Springville Dermatology
Springville, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.